DAVID MICHAEL LEWINSOHN, MD
Osteopathic Medicine at Sam Jackson Park Rd, Portland, OR
License number
Oregon MD21489
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
Oregon MD21489
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Phone
(503) 494-1620
Personal information
See more information about DAVID MICHAEL LEWINSOHN at radaris.comName
Address
Phone
3048 Ashley Loop, Eugene, OR 97405
3048 Ashley Ct, Eugene, OR 97405
2687 Vista Ave, Portland, OR 97201
Professional information
Professor At Ohsu
Position:
Professor at OHSU, Professor at VA Medical Center, Professsor at Oregon Health & Science University
Location:
Portland, Oregon Area
Industry:
Research
Work:
OHSU
since Sep 1998
-
Professor
VA Medical Center
since 1998
-
Professor
Oregon Health & Science University
since 1998
-
Professsor
Infectious Disease Research Institute
1993 - 1998
-
Research Scientist
Education:
University of Washington School of Medicine 1993 - 1998
Fellowship, Pulmonary and Critical Care Medicine Stanford University 1982 - 1989
MD, Medicine Stanford University 1982 - 1989
PhD, Cancer Biology Haverford College 1978 - 1982
BA, Biology
Fellowship, Pulmonary and Critical Care Medicine Stanford University 1982 - 1989
MD, Medicine Stanford University 1982 - 1989
PhD, Cancer Biology Haverford College 1978 - 1982
BA, Biology
David Michael Lewinsohn, Portland OR
Specialties:
Pulmonologist
Address:
3181 Sw Sam Jackson Park Rd, Portland, OR 97239
3710 Sw Us Veterans Hospital Rd, Portland, OR 97239
3710 Sw Us Veterans Hospital Rd, Portland, OR 97239
Education:
Stanford University, School of Medicine - Doctor of Medicine
University of Washington Medical Center - Fellowship - Pulmonary Disease and Critical Care Medicine (Internal Medicine)
UCSF Medical Center - Residency - Internal Medicine
University of Washington Medical Center - Fellowship - Pulmonary Disease and Critical Care Medicine (Internal Medicine)
UCSF Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Critical Care Medicine (Internal Medicine), American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)
Dr. David M Lewinsohn, Portland OR - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Pulmonology
Address:
3710 SW Us Veterans Hospital Rd, Portland 97239
(503) 220-8262 (Phone)
2687 SW Vista Ave, Portland 97201
(503) 220-8262 (Phone)
2687 SW Vista Ave, Portland 97201
Certifications:
Critical Care Medicine, 1997, Internal Medicine, 1992, Pulmonary Disease, 2007
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Stanford University
Graduated: 1989
University Of California-San Francisco
University Of Washington
Stanford University
Graduated: 1989
University Of California-San Francisco
University Of Washington
David Michael Lewinsohn, Portland OR
Specialties:
Internal Medicine, Critical Care Medicine, Pulmonary Disease
Work:
Ohsu Pulmonary & Critical Care Medicine
3181 SW Sam Jackson Park Rd, Portland, OR 97239
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Education:
Stanford University (1989)
Methods For Producing An Immune Response To Tuberculosis
US Patent:
8101192, Jan 24, 2012
Filed:
Sep 29, 2010
Appl. No.:
12/894051
Inventors:
David Lewinsohn - Portland OR, US
Deborah Lewinsohn - Portland OR, US
Deborah Lewinsohn - Portland OR, US
Assignee:
Oregon Health & Science University - Portland OR
The United States of America as represented by the Department of Veterans Affairs - Washington DC
The United States of America as represented by the Department of Veterans Affairs - Washington DC
International Classification:
A61K 39/38, A61K 39/00, A61K 39/02, A61K 39/385, A61K 39/04
US Classification:
4242481, 4241841, 4241851, 4241901, 4241931, 42419711, 4242341
Abstract:
Methods for producing an immune response to (Mtb) are disclosed herein. In several examples, the immune response is a protective immune response. In additional embodiments, methods are disclosed for preventing an infection with Mtb, or treating an infection with Mtb. Pharmaceutical compositions for the prevention and/or treatment of tuberculosis are also disclosed.
Methods For Detecting A Infection
US Patent:
8053181, Nov 8, 2011
Filed:
Mar 14, 2007
Appl. No.:
12/282862
Inventors:
David M. Lewinsohn - Portland OR, US
Deborah A. Lewinsohn - Portland OR, US
Deborah A. Lewinsohn - Portland OR, US
Assignee:
Oregon Health & Science University - Portland OR
The United States of America as represented by the Department of Veterans Affairs - Washington DC
The United States of America as represented by the Department of Veterans Affairs - Washington DC
International Classification:
C12Q 1/00, G01N 33/53, G01N 33/567, G01N 33/554, G01N 33/569
US Classification:
435 4, 435 71, 435 72, 435 732
Abstract:
Methods for detecting an infection with (Mtb) in a subject are disclosed. The methods include detecting the presence of CD8+T cells that specifically recognize an Mtb polypeptide. The methods include in vitro assays for detecting the presence of CD8+T cells in a biological sample, and in vivo assays that detect a delayed type hypersensitivity reaction. The methods can also include detecting Mtb polypeptides and polynucleotides. Reagents for the detection of an Mtb infection are also disclosed.
Methods For Detecting A Mycobacterium Tuberculosis Infection
US Patent:
2012028, Nov 8, 2012
Filed:
Nov 19, 2010
Appl. No.:
13/510869
Inventors:
David M. Lewinsohn - Portland OR, US
Deborah A. Lewinsohn - Portland OR, US
Deborah A. Lewinsohn - Portland OR, US
International Classification:
G01N 33/569, C12Q 1/68, A61K 49/00
US Classification:
424 91, 435 71, 435 615, 435 612
Abstract:
Methods for detecting an infection with Mtb in a subject are disclosed. The methods include detecting the presence of CD8 T cells that specifically recognize an Mtb polypeptide. The methods include in vitro assays for detecting the presence of CD8 T cells in a biological sample, and in vivo assays that detect a delayed type hypersensitivity reaction. The methods also include detecting Mtb polypeptides and polynucleotides.
Methods For Producing An Immune Response To Tuberculosis
US Patent:
2012023, Sep 20, 2012
Filed:
Nov 19, 2010
Appl. No.:
13/510862
Inventors:
David M. Lewinsohn - Portland OR, US
Deborah A. Lewinsohn - Portland OR, US
Deborah A. Lewinsohn - Portland OR, US
International Classification:
A61K 39/04, C07K 7/08, C12N 15/31, A61K 35/00, C12N 1/21, A61K 39/385, A61P 37/04, A61P 31/06, C12N 15/74, C07K 7/06, A61K 31/7088
US Classification:
4241901, 530328, 530327, 530326, 536 237, 424 932, 514 44 R, 4353201, 4352523
Abstract:
Methods for producing an immune response to (Mtb) are disclosed herein. In several examples, the immune response is a protective immune response. In additional embodiments, methods are disclosed for inhibiting an infection with Mtb, preventing an infection with Mtb, or treating an infection with Mtb. Pharmaceutical compositions for the inhibition, prevention and/or treatment of tuberculosis are also disclosed.
Methods For Detecting A Mycobacterium Tuberculosis Infection
US Patent:
2011018, Jul 28, 2011
Filed:
Sep 22, 2009
Appl. No.:
13/119938
Inventors:
Deborah A. Lewinsohn - Portland OR, US
David M. Lewinsohn - Portland OR, US
David M. Lewinsohn - Portland OR, US
International Classification:
C12Q 1/68, G01N 33/569
US Classification:
435 612, 435 724, 435 615
Abstract:
Methods for detecting an infection with (Mtb) in a subject are disclosed, wherein the subject is a child, a subject with a latent infection. Method are also disclose for detecting an extra-pulmonary infection in a subject. The methods include detecting the presence of CD8 T cells that specifically recognize an Mtb polypeptide. The methods include in vitro assays for detecting the presence of CD8 T cells in a biological sample.
Methods For Producing An Immune Response To Tuberculosis
US Patent:
2009012, May 14, 2009
Filed:
Mar 14, 2007
Appl. No.:
12/282865
Inventors:
David Lewinsohn - Portland OR, US
Deborah Lewinsohn - Portland OR, US
Deborah Lewinsohn - Portland OR, US
International Classification:
A61K 38/16, A61K 38/08, A61P 37/04, C07K 7/06, C07H 21/04, C12N 1/21, C12N 15/63, C07K 7/08, A61K 31/7088, A61K 38/10
US Classification:
514 12, 514 15, 514 14, 514 13, 514 44, 530328, 530327, 530326, 536 231, 4353201, 4352523
Abstract:
Methods for producing an immune response to (Mtb) are disclosed herein. In several examples, the immune response is a protective immune response. In additional embodiments, methods are disclosed for preventing an infection with Mtb, or treating an infection with Mtb. Pharmaceutical compositions for the prevention and/or treatment of tuberculosis are also disclosed.